Zydus Partners Medicure To Launch First Branded Drug In US

12 Mar 2018

• By Penelope MacRae

Zydus Cadila is teaming up with Canada’s Medicure Inc to launch cholesterol control medication Zypitamag, its first branded drug in the key US market, as the Indian firm drives ahead with a strategy of diversifying from low-priced generics.

Pharma pills — ZYDUS AND MEDICURE HAVE JOINED HANDS IN THE US

Zydus Cadila announced it has struck a deal with a subsidiary of cardiovascular drug discovery firm Medicure Inc. to market cholesterol management drug Zypitamag in the US. The debut of Zypitamag (pitavastatin magnesium) “marks the first branded product launch for Zydus in the US,” the Indian company said in a statement.

The proprietary drug’s launch is part of Zydus Cadila’s quest to explore “new pathways in pharmaceutical technology,” said company managing...